Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Wyles, David
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure. [electronic resource] - Hepatology (Baltimore, Md.) 12 2017 - 1794-1804 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-3350
10.1002/hep.29358 doi
Adult
Aged
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Female
Hepatitis C--drug therapy
Humans
Male
Middle Aged
Treatment Failure
Treatment Outcome
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure. [electronic resource] - Hepatology (Baltimore, Md.) 12 2017 - 1794-1804 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-3350
10.1002/hep.29358 doi
Adult
Aged
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Female
Hepatitis C--drug therapy
Humans
Male
Middle Aged
Treatment Failure
Treatment Outcome